Biogen Inc (BUE:BIIB)
ARS 18636 201.5 (1.09%) Market Cap: 28.46 Til Enterprise Value: 33.64 Til PE Ratio: 27.95 PB Ratio: 2.13 GF Score: 53/100

Biogen Inc at Cowen HealthCare Conference Transcript

Mar 02, 2020 / 04:20PM GMT
Philip M. Nadeau
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Good morning and welcome once again to Cowen and Company's 40th Annual Health Care Conference. I'm Phil Nadeau, one of the biotech analysts here in Cowen, and it's my pleasure to moderate a fireside chat with Biogen, one of the bellwethers of the industry. We're happy to have with us today, Michel Vounatsos, the CEO; as well as Joe Mara from IR; and Jeff Capello, the CFO, here in the front row.

Questions & Answers

Philip M. Nadeau
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Michel, maybe you can start with just giving us your vision for Biogen over the next 5 years. How is the company going to create shareholder value? And what will differentiate it as investment versus the other large caps?

Michel Vounatsos
Biogen Inc. - CEO & Director

So good morning, everyone. I'll be -- might be making some forward-looking statements or -- that contain risks and uncertainties, so I refer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot